IL204728A0 - Methods and compounds for treating retinol-related diseases - Google Patents

Methods and compounds for treating retinol-related diseases

Info

Publication number
IL204728A0
IL204728A0 IL204728A IL20472810A IL204728A0 IL 204728 A0 IL204728 A0 IL 204728A0 IL 204728 A IL204728 A IL 204728A IL 20472810 A IL20472810 A IL 20472810A IL 204728 A0 IL204728 A0 IL 204728A0
Authority
IL
Israel
Prior art keywords
compounds
methods
related diseases
retinol
treating
Prior art date
Application number
IL204728A
Other languages
English (en)
Original Assignee
Revision Therapeutics Inc
Sirion Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Revision Therapeutics Inc, Sirion Therapeutics Inc filed Critical Revision Therapeutics Inc
Publication of IL204728A0 publication Critical patent/IL204728A0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL204728A 2007-09-27 2010-03-25 Methods and compounds for treating retinol-related diseases IL204728A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US97576507P 2007-09-27 2007-09-27
US98132207P 2007-10-19 2007-10-19
PCT/US2008/076499 WO2009042444A2 (en) 2007-09-27 2008-09-16 Methods and compounds for treating retinol-related diseases

Publications (1)

Publication Number Publication Date
IL204728A0 true IL204728A0 (en) 2010-11-30

Family

ID=40512081

Family Applications (1)

Application Number Title Priority Date Filing Date
IL204728A IL204728A0 (en) 2007-09-27 2010-03-25 Methods and compounds for treating retinol-related diseases

Country Status (8)

Country Link
EP (1) EP2205234A4 (enrdf_load_stackoverflow)
JP (1) JP2010540541A (enrdf_load_stackoverflow)
KR (1) KR20100097098A (enrdf_load_stackoverflow)
CN (1) CN101873852A (enrdf_load_stackoverflow)
AU (1) AU2008305303A1 (enrdf_load_stackoverflow)
CA (1) CA2699773A1 (enrdf_load_stackoverflow)
IL (1) IL204728A0 (enrdf_load_stackoverflow)
WO (1) WO2009042444A2 (enrdf_load_stackoverflow)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2202223B1 (en) * 2007-10-18 2017-01-25 Takeda Pharmaceutical Company Limited Heterocyclic compound as blood rbp4 lowering agent
US8853215B2 (en) 2009-04-16 2014-10-07 Takeda Pharmaceutical Company Limited Derivatives of N-acyl-N′-phenylpiperazine useful (inter alia) for the prophylaxis or treatment of diabetes
JP5951625B2 (ja) * 2010-11-24 2016-07-13 ザ・トラスティーズ・オブ・コランビア・ユニバーシティー・イン・ザ・シティー・オブ・ニューヨークThe Trustees Of Columbia University In The City Of New York 加齢性黄斑変性症およびシュタルガルト病の処置のための非レチノイドrbp4アンタゴニスト
RU2013129999A (ru) * 2010-12-02 2015-01-10 Дайити Санкио Компани, Лимитед Модифицированный одноцепочечный полинуклеотид
US9333202B2 (en) 2012-05-01 2016-05-10 The Trustees Of Columbia University In The City Of New York Non-retinoid antagonists for treatment of age-related macular degeneration and stargardt disease
US9938291B2 (en) 2013-03-14 2018-04-10 The Trustess Of Columbia University In The City Of New York N-alkyl-2-phenoxyethanamines, their preparation and use
WO2014152018A1 (en) 2013-03-14 2014-09-25 The Trustees Of Columbia University In The City Of New York Octahydrocyclopentapyrroles, their preparation and use
WO2014151936A1 (en) 2013-03-14 2014-09-25 The Trustees Of Columbia University In The City Of New York Octahydropyrrolopyrroles, their preparation and use
ES2705247T3 (es) 2013-03-14 2019-03-22 Univ Columbia 4-fenilpiperidinas, su preparación y uso
EP4036094A1 (en) 2014-04-30 2022-08-03 The Trustees of Columbia University in the City of New York Substituted 4-phenylpiperidines, their preparation and use
MA39688B1 (fr) * 2014-10-24 2021-02-26 Takeda Pharmaceuticals Co Composés hétéroaryle pour le traitement de maladies ophtalmiques
JP6646586B2 (ja) * 2014-10-24 2020-02-14 武田薬品工業株式会社 複素環化合物
AU2021265838A1 (en) * 2020-04-29 2022-10-20 Saliogen Therapeutics, Inc. Compositions and methods for treatment of inherited macular degeneration

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2526534A (en) * 1948-07-03 1950-10-17 Dow Chemical Co Di-(aryloxy)-methanes
US4255152A (en) * 1978-09-05 1981-03-10 Ciba-Geigy Corporation Process for the dyeing of hydrophobic fibres
JPS577480A (en) * 1980-06-16 1982-01-14 Sankyo Co Ltd 4-alkoxy-6-phenoxymethyl-2-pyrone derivative
US7510710B2 (en) * 2004-01-08 2009-03-31 The Regents Of The University Of Colorado Compositions of UCP inhibitors, Fas antibody, a fatty acid metabolism inhibitor and/or a glucose metabolism inhibitor
US20090155903A1 (en) * 2004-03-19 2009-06-18 Myriad Genetics, Incorporated Pharmaceutical composition and method
WO2005116010A1 (en) * 2004-05-26 2005-12-08 Merck Frosst Canada Ltd. Ep4 receptor agonist, compositions and methods thereof

Also Published As

Publication number Publication date
JP2010540541A (ja) 2010-12-24
WO2009042444A2 (en) 2009-04-02
CN101873852A (zh) 2010-10-27
EP2205234A2 (en) 2010-07-14
EP2205234A4 (en) 2010-12-22
WO2009042444A3 (en) 2009-05-14
KR20100097098A (ko) 2010-09-02
CA2699773A1 (en) 2009-04-02
AU2008305303A1 (en) 2009-04-02

Similar Documents

Publication Publication Date Title
IL257418A (en) Methods for treating addiction
IL204728A0 (en) Methods and compounds for treating retinol-related diseases
SI2308885T1 (sl) Nove spojine in postopki za zdravljenje
PT2252148T (pt) Métodos de tratamento da síndrome do intestino irritável
EP2170311A4 (en) COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING AUTOIMMUNE DISEASES
IL200862A0 (en) 3-imidazolyl-indoles for the treatment of proliferative diseases
IL209216A0 (en) Methods for preventing and treating neurodegenerative diseases
EP2262366A4 (en) COMPOUNDS AND METHODS FOR TREATING STROGEN RECEPTOR-RELATED DISEASES
EP2365747A4 (en) METHODS OF TREATING GASTROINTESTINAL DISEASES
EP2244690A4 (en) METHOD AND COMPOSITIONS FOR THE TREATMENT OF SKIN DISEASES AND DRESSES
IL238394A0 (en) Cancer treatment method
IL199689A0 (en) Compounds and method for treatment of cancer
PL2131841T3 (pl) Sposoby leczenia bólu ostrego
EP2144888A4 (en) METHODS OF TREATING CANCER
EP2225226A4 (en) COMPOUNDS AND METHOD FOR THE TREATMENT OF CANCER
ZA200808076B (en) Methods for preventing and treating amyloidogenic diseases
GB0718684D0 (en) Treatment method
EP2088862A4 (en) METHOD OF TREATING CANCER
EP2039392A4 (en) DEVICE FOR PHYSIOTHERAPY TREATMENT OF DISEASES OF VARIOUS AITIOLOGIES
EP2164494A4 (en) Methods of Treatment
GB201008346D0 (en) Methods and compounds for phototransfer
IL226363A0 (en) Compounds and methods for treating cancer
IL205339A0 (en) Compounds and methods for the treatment of cancer
EP2203432A4 (en) PROCESSING METHOD
EP2278982A4 (en) COMPOSITIONS AND METHODS OF TREATING NEURODEEGENERATIVE ILLNESSES